secwatch.observer — SEC 8-K summary
======================================

Issuer:     Comera Life Sciences Holdings, Inc. (—)
CIK:        0001907685
Form:       8-K
Filed at:   2023-05-19T23:59:59+00:00
Accession:  0000950170-23-023269
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Comera Life Sciences receives Nasdaq delisting notice for failing MVLS standard
-------------------------------------------------------------------------------

- Received Nasdaq determination letter on May 18, 2023 for non-compliance with $35M MVLS minimum.
- Grace period ended May 17, 2023; stock had not achieved $35M MVLS for 10 consecutive days.
- Must request hearing by May 25, 2023 to appeal; otherwise delisting on May 30, 2023.
- Company intends to request a hearing; trading will continue until Panel decision.
- If delisted, common stock expected to trade on OTC Markets Group.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1907685/000095017023023269/0000950170-23-023269-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1907685/000095017023023269/cmra-20230518.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-023269

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer